PKU Resources (00618) is pleased to announce that it is expected to achieve a profit of approximately 1.8 billion to 2 billion yuan in the mid-term period, turning a loss into a profit on a year-on-year basis.
Beijing University Resources (00618) issued an announcement, expecting that the group will achieve... by the end of the 6-month period ending September 30, 2025.
PKU RESOURCES (00618) announced that it is expected to achieve a surplus of approximately RMB 1.8 billion to RMB 2 billion for the six-month period ending on September 30, 2025. In contrast, for the six-month period ending on September 30, 2024, the Group incurred a loss of approximately RMB 1.355 billion.
The expected surplus for the Group is mainly due to: (i) in August 2025, the company injected all the equity of its wholly-owned subsidiary, Antaeus International Investment Group (Hong Kong) Limited, into a partnership enterprise, generating a sales income of approximately RMB 2.314 billion. The company sold 16 subsidiary companies, of which 6 are engaged in property development business in China; (ii) after the completion of the aforementioned transaction, the Group no longer has any real estate development projects in the development stage, resulting in a significant reduction in financial expenses related to the Group's sale and expected liability provisions.
Related Articles

CSPC PHARMA (01093): Selective 5-HT2A receptor agonist (SYH2056 tablets) receives clinical trial approval in China.

FEG HOLDINGS (01413) issues profit warning, expecting a comprehensive loss of approximately HK$20 million to HK$30 million in the middle term for shareholders from continuing operations.

KN HOSPITAL (02120) repurchased 64,200 shares for HK$727,000 on November 21st.
CSPC PHARMA (01093): Selective 5-HT2A receptor agonist (SYH2056 tablets) receives clinical trial approval in China.

FEG HOLDINGS (01413) issues profit warning, expecting a comprehensive loss of approximately HK$20 million to HK$30 million in the middle term for shareholders from continuing operations.

KN HOSPITAL (02120) repurchased 64,200 shares for HK$727,000 on November 21st.






